Objectives: Circadian rhythms are affected in many neurological disorders.
mortality related to epilepsy, the mechanisms of which are poorly understood. 3 We and others have shown that epileptic Kcna1-null mice, a model of SUDEP, 4 have a circadian pattern of seizures, aberrant rest-activity rhythms, and progressively increasing seizure burden and rest deficit preceding death. [5] [6] [7] Such effects of seizures have not been as extensively defined in humans, despite the preponderance of sleep complaints among people with epilepsy. 8 Reciprocal interactions between seizures and sleep regulation may constitute a mechanism that drives development of complications in epilepsy and possibly contributes to SUDEP. Understanding the mechanisms of disrupted circadian rhythms and sleep may serve to inform future therapies. Sleep is one of many physiological processes with a circadian rhythm that is regulated by a core pacemaker in the suprachiasmatic nucleus (SCN). Activity in the SCN is strongly entrained by light but is also influenced by emotional and metabolic state. 9, 10 Central to SCN function is a transcription-translation autoregulatory feedback loop of "clock" proteins, namely BMAL1, CLOCK, PER1-3, and CRY1/2. CLOCK:BMAL1 heterodimers bind to E-box promoter sites of Per and Cry, promoting transcription. 11 Once translated, PER and CRY are subject to phosphorylation, allowing subsequent inhibition of the CLOCK:BMAL complex. 12, 13 Many genes in the SCN show a circadian oscillation; such clock-controlled genes affect many cellular functions including excitability via differential expression of several membrane-bound ion channels. 14, 15 In the context of epilepsy, seizures may drive input to the SCN, potentially causing aberrant entrainment and neuronal hyperexcitability. Mechanistically, CLOCK-mediated translational activation of clock-controlled genes via acetylation of histones and their binding partner BMAL1 enables transcription and the stability of the CLOCK:BMAL1 heterodimer at its promoter site. 16, 17 BMAL1 acetylation can be counterregulated by sirtuin 1 (Sirt1), a nicotinamide-dependent deacetylase that is expressed in a circadian manner and whose absence is known to be associated with disrupted behavioral rhythms. 18 Acetylation state of BMAL1 has been shown to be important in CRY-mediated inhibition of the CLOCK: BMAL1 transcription factor and normal entrainment of circadian behavior. 17, 19 Several studies have shown that mutations or deletion in many of these core genes impacts circadian rhythms, implicating their critical role in circadian rhythm generation. 11, 20, 21 In keeping with previous literature, we demonstrate that both diurnal and circadian rest-activity and sleep patterns are altered in epileptic Kcna1-null mice. We present novel evidence that seizure burden alone does not correlate with degree of sleep disruption; however, oscillations in transcript levels of several core clock genes are attenuated under diurnal and constant dark conditions. We hypothesized that perturbed regulation of clock-controlled gene transcription may contribute to disrupted rhythms in Kcna1-null mice.
| MATERIALS AND METHODS

| Animals
All procedures were approved by the institutional animal care and use committee at the University of Wisconsin School of Medicine and Public Health. Animals were housed in the vivarium at the University of Wisconsin. Heterozygous mice (C3HeB.129S7-Kcna1tm1Tem/J; Jackson Laboratory, Bar Harbor, ME, USA) lacking one allele coding for the 1.1 isoform of voltage-gated potassium channels (Kv1.1) were used to produce mice of all genotypes. Homozygous knockout (KO) mice (Kcna1-null animals) develop spontaneous seizures after the second postnatal week of life.
| Lighting conditions
We housed animals in either diurnal (12 hour-12 hour, light-dark, [LD]) or constant dark (DD) lighting conditions for experiments. Low-intensity red lighting was used for all necessary handling procedures and husbandry during lights-off.
| Actigraphy
We housed mice individually under either LD or DD in well-ventilated, cylindrical Plexiglas cages, 6 inches in diameter and 12 inches in height. An infrared motion sensor suspended above the mice recorded gross locomotion. Individual movements were grouped in 1-minute bins and plotted across time for analysis. As nocturnal animals, LD- Electroencephalographic (EEG) electrode implantation was performed at postnatal day (P) 34-36 for all animals as previously described. 22 Briefly, mice were anesthetized with isoflurane (5% induction, 1-2% maintenance). After confirming plane of anesthesia, we made an incision to expose the skull and implanted two stainless steel screw electrodes for EEG recording (bregma +1.5 mm and 1 mm right, bregma −3 mm and 1 mm left, and lambda −1 mm at midline) and two stainless steel braided wires in the nuchal muscles for electromyographic (EMG) recording. After a 72-hour recovery, we transferred mice into individual EEG acquisition chambers and allowed a >12-hour acclimation period. We acquired EEG and EMG signals continuously for two 5-day periods in diurnal or constant lighting, with 1 day excluded from analysis while we transitioned animals between lighting conditions, ensuring ad libitum access to food and water. Recordings were digitized with an Xltek amplifier (Natus Medical Incorporated, Pleasanton, CA, USA) sampling at 1024 Hz. Two independent reviewers identified seizures in the video-EEG records. For sleep staging, we processed recordings with bandpass (1-70 Hz for EEG and 3-500 Hz for EMG) and notch (60 Hz) filters and imported them into Sirenia Sleep Pro analysis software (Pinnacle Technology, Lawrence, KS, USA). We manually scored vigilance states in 4-second epochs. We identified waking states as those epochs with high EMG amplitude, as shown in Figure S1A , and those with relatively quiescent EMG as sleep. To further differentiate sleep, we used predominant EEG frequencies to score non-rapid eye movement sleep (NREM) and rapid eye movement sleep (REM) as those with high delta (1-4 Hz, Figure S1B ) and high theta (5-7 Hz, Figure S1C ) activity, respectively.
Key Points
| Real-time polymerase chain reaction and Western blotting
We harvested tissue of wild-type (WT) and Kcna1-null mice (P30 ± 1 or P45 ± 3) at Zeitgeber time (ZT) 0, 6, 12, and 18 (n = 4-6), using dim red light for any time point when lights were off. Mice included DD cohorts that were held in constant darkness for 8 days prior to tissue procurement. The anterior hypothalamic region (~2 mm 3 ) immediately surrounding the SCN was rapidly isolated, bisected along the midline, and flash frozen in liquid nitrogen. All samples were stored at −80°C until they were processed simultaneously. We isolated total mRNA using TRI Reagent (SigmaAldrich, Saint Louis, MO, USA) and standardized concentrations across samples. We synthesized first-strand cDNA from linearized total RNA with Superscript III First-Strand Synthesis SuperMix (Invitrogen, Carlsbad, CA, USA) primed with random hexamers. We then conducted real-time polymerase chain reaction with SYBR Green reagents and monitored amplification of target gene cDNA amplicons following a hot-start thermocycle protocol beginning with 2 minutes at 95°C, followed by 40 amplification cycles (15 seconds at 95°C, 30 seconds at 60°C, 30 seconds at 72°C, and 6-second imaging at 76°C). We confirmed primer specificity via melt curve analysis (60-95°C in 0.5°C steps). Primer sequences are as follows: Bmal1, forward, 5′-CCCTAGGCCTTCATTGCACC-3′; reverse, 5′-CATAT TCTAACTGGTAGTCAGTGG-3′; Clock, forward, 5′-AA GATTCTGGGTCTGACAAT-3′; reverse, 5′-TTGCAGCTT GAGACATCGCT-3′; mPer1, forward, 5′-GAAAGAAAC CTCTGGCTGTTCCT-3′; reverse, 5′-GCTGACGACGGAT CTTTCTTG-3′; mPer2, forward, 5′-GCATATTCTAAC TGGTAGTCAGTGG-3′; reverse, 5′-GTCTGAAGGCATC-ATCAGG-3′; Sirt1, forward, 5′-TCTGTCTCCTGTGGGA-TTCCT-3′; reverse, 5′-GATGCTGTTCGAAAGGAA-3′, and Gapdh, forward, 5′-GACCTCAACTACATGGTCT ACA-3′; reverse, 5′-ACTCCACGACATACTCAGCAC-3′. We analyzed transcript levels with the 2 ΔCT method, normalizing to the housekeeping gene Gapdh. We isolated total protein using radioimmunoprecipitation assay buffer containing phosphatase and protease inhibitors. Following isolation, we ran Western blots, resolving protein samples in 4%-15% gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferring them to polyvinylidene difluoride membranes. We blocked membranes with a 5% skim milk-Tris-buffered saline with Tween solution for 1 hour at room temperature. We then hybridized membrane-bound proteins overnight at 4°C with primary antibodies diluted in the above milk:Trisbuffered saline with Tween solution: SIRT1 (1:1000; Millipore, Billerica, MA, USA), PER1 and CLOCK (1:1000 and 1:100, respectively; Santa Cruz Biotechnology, Santa Cruz, CA, USA), BMAL1 (1:1000; Abcam, Cambridge, MA, USA), PER2 (1:1000; Millipore), and β-actin (1:10 000; MP Biomedicals, Irvine, CA, USA). We then incubated membranes with appropriate secondary antibodies conjugated with hydrogen peroxidase (1:10 000, Santa Cruz Biotechnology) for 1 hour prior to chemiluminescent imaging (UVP ChemiDoc-it) with SuperSignal West Femto ECL reagents (Pierce Biotechnology, Rockford, IL, USA). A common loading control was run in duplicate across all blots. We quantified target protein expression by normalizing signal intensity within samples relative to β-actin and then across blots relative to the median protein:β-actin ratio of the loading controls across all blots.
| Data analysis
We analyzed data utilizing custom MATLAB scripts (Prism; GraphPad Software, La Jolla, CA, USA) and VisionWorks LS imaging software (UVP, Upland, CA, USA). We calculated circadian period length using a chisquare periodogram analysis. To test differences in period length and time spent in each vigilance state, we used multiple t tests with a Holm-Sidak correction for multiple comparisons. We used the two-sample Kolmogorov-Smirnov (2K-S) test statistic to evaluate factorial differences in cumulative distribution functions of bout lengths between epileptic and WT animals according to vigilance state (wake, NREM, and REM) and lighting condition. Expression of protein and mRNA levels was compared between Kcna1-null and WT mice with statistical significance of circadian oscillations and individual time points determined via two-way analysis of variance (ANOVA) with Sidak correction for multiple comparisons. For all statistical analyses, we set the threshold of significance to P = .05.
| RESULTS
| Disrupted diurnal and circadian rest-activity patterns
In our WT controls held in LD, locomotor activity patterns are elevated during dark periods and decreased during light periods, as had been previously reported. 23 When WT animals were placed in DD, timing of locomotor activity reverts to the period of the internal circadian rhythm, which manifests as a daily advance of when active periods begin as reported previously ( Figure 1A , left). 23, 24 In Kcna1-null mice, however, rest-activity patterns are largely arrhythmic in LD and DD ( Figure 1A , right). In our cohorts, using chisquare periodograms, we found circadian period tended to be longer in epileptic mice, in both LD (KO, 29.38 ± 1.74, n = 9 vs WT, 23.71 ± 0.13, n = 6, P < .05, Sidak t test) and DD (KO, 27.26 ± 1.1627, n = 9 vs WT, 23.68 ± 0.15, n = 20, P < .01, Sidak t test; Figure 1B ), demonstrating how entrainment and circadian control of behavior is significantly disrupted in Kcna1-null mice.
| Altered vigilance patterns and sleep architecture in Kcna1-null mice
Because actigraphy provides only an indirect measure of sleep patterns, we then employed video-EEG-based analysis of sleep in Kcna1-null mice and WT controls. Consistent with our actigraphy results, we found that Kcna1-null mice spent significantly more time awake than WT littermates in both LD and DD (Figure 2A , WT, 53.24 ± 0.73%, n = 28 days, 5 mice vs KO, 66.53 ± 1.54%, n = 50 days, 7 mice, P < .0001, Sidak t test; Figure 2B, WT, 50.47 ± 0.97%, n = 29 days, 6 mice vs KO, 70.0 ± 1.258%, n = 35 days, 7 mice, P < .0001, Sidak t test). As shown in the daily values of a representative animal ( Figure 2C and 2D) , the increase in time spent awake is consistent across days of recording. This imbalance of sleep is mainly due to decreased time in NREM, again independent of lighting condition ( Figure 2A , LD: WT, 40.57 ± 0.69% vs KO, 29.68 ± 1.51%, P < .0001, Sidak; Figure 2B , DD: WT, 43.64 ± 0.92% vs KO, 26.84 ± 1.18%, P < .0001, Sidak). Time spent in REM was also significantly decreased in epileptic animals in both LD (Figure 2A , WT, 6.18 ± 0.26% vs KO, 3.794 ± 0.1983%, P < .0001, Sidak) and DD ( Figure 2B , WT, 5.89 ± 0.27% vs KO, 3.153 ± 0.1496%, P < .05, Sidak). When we evaluated sleep architecture by compiling bout lengths according to genotype, vigilance state, and lighting condition, we found that all categories except diurnal REM had significantly altered distributions. It is important to note that maximal bout lengths (indicated by triangles above the cumulative distribution function plots in Figure 2E -J) are comparable within condition, suggesting that differences are chiefly in bouts with less than maximal durations. As shown in Figure 2E and 2F, wake bout lengths of mutant animals in both conditions are rightshifted, indicating greater likelihood of longer bouts (P < .0001, 2K-S test). Distribution of NREM bout lengths for LD and DD is shown in Figure 2G and 2H, respectively. Whereas distribution of NREM bout lengths of Kcna1-null mice shifted to the left of WT controls in DD (P < .0001, 2K-S test), they were right-shifted for LD condition, indicating generally longer bout lengths (P < .0001, 2K-S test) despite reduced overall time in NREM. However, considering the total percentages (Figure 2A) , NREM is likely occurring in fewer, albeit longer, bouts in Kcna1-null mice under LD. Finally, REM bout distribution was not altered in Kcna1-null mice compared to WT littermates in LD ( Figure 2I , P = .91, 2K-S test), but was affected in DD ( Figure 2J , P < .0001, 2K-S test).
| Correlation between seizure frequency and sleep-wake patterns
We have previously reported that Kcna1-null mice can have up to 78 seizures over a period of 10 days, which manifest in one of four electrographically and behaviorally discrete seizure types. 6 Given the aberrant circadian restactivity patterns and sleep architecture, we sought to determine the extent to which seizure burden affects sleep architecture by first correlating daily seizure counts with several metrics of sleep, including mean length and number of bouts in each vigilance state. As illustrated in Figure 3 , we discovered that the number of wake bouts in an epileptic mouse increased slightly with total number of seizures per day, although the correlation was not statistically significant (R 2 = 0.045, P = .14). Similarly, we found no relationship between seizures and other vigilance states (data not shown). Although we consistently observed extended, postictal periods of wakefulness, this analysis suggests that seizure frequency alone is insufficient in explaining the severely disrupted locomotor and vigilance patterns in Kcna1-null animals.
| Aberrant oscillation in clock genes
We then investigated other mechanisms of sleep regulation, specifically whether the expression of clock genes is altered. To this end, we investigated mRNA levels of Clock, Bmal1, Per1, and Per2 in Kcna1-null and WT mice (n = 3-4 /time point/genotype/lighting condition). In LD, we found that all genes except Bmal1 had significant oscillations indicated by a main effect of time (Figure 4C ,
show rest-activity patterns of Kcna1-null (n = 9) and wild-type (WT; n = 6) mice held in diurnal (12-12, light-dark) and constant dark lighting conditions. WT mice entrained to diurnal light condition concentrate their locomotion to active periods during lights-off, the onset of which advances when they are transitioned to constant dark or free-running condition (A, left). Locomotor activity of Kcna1-null mice was markedly elevated during subjective day, indicating an inability in entraining to light cues and arrhythmic circadian behavior (A, right). Chi-square periodograms of rest-activity patterns revealed that mean circadian period in epileptic animals was drastically increased over WT littermates (B; t test, **P < .01)
Clock, F 3, 17 = 4.863, P < .05; Figure 4E , Per1, F 3, 16 = 66.28, P < .0001; Figure 4G , Per2, F 3, 17 = 9.592, P < .001, two-way ANOVA). Additionally, we found a main effect of genotype on the LD expression of Clock (Figure 4C , F 1, 17 = 24.25, P = .0001, two-way ANOVA), Per1 ( Figure 4E , F 1, 16 = 20.90, P < .001, two-way ANOVA), and Per2 ( Figure 4G , F 1, 17 = 7.957, P < .05, two-way ANOVA), where transcription was diminished in Kcna1-null mice when compared to WT controls. Assessment of individual time points revealed a decrease in levels of Clock at ZT 0 and 6 ( Figure 4C , P < .001, Sidak multiple comparison) and Per1 at ZT 6 ( Figure 4E , P < .001, Sidak multiple comparison) in mutants compared to WT mice housed in LD. Interestingly, these time points often corresponded to peak daily expression, emphasizing the diminished drive of transcription in epileptic mice. In DD, we found that oscillations in transcription persisted in Per1 ( Figure 4F , F 3, 21 = 35.42, P < .0001, two-way ANOVA) and Per2 ( Figure 4H , F 3, 21 = 9.014, P < .001, two-way ANOVA). We also found that in DD only Per1 ( Figure 4F , F 1, 21 = 5.159, P < .05, two-way ANOVA) showed a main effect of genotype, with reduced transcription in Kcna1-null animals. Given the changes in transcriptional profiles of several clock genes in our Kcna1-null model, we then examined whether associated protein levels are disrupted as well F I G U R E 2 Electroencephalographybased sleep scoring shows perturbed sleep architecture in epileptic Kcna1-null mice (red), which spend more time awake and less time in either non-rapid eye movement sleep (NREM) or rapid eye movement sleep (REM) than wild-type (WT; blue) in both diurnal (A; WT, 28 days, 5 mice; knockout [KO], 50 days, 7 mice) and constant (B; WT, 29 days, 6 mice; KO, 35 days, 7 mice) conditions (**P < .01). Daily time awake for representative animals over 5 days of diurnal (C) and constant (D) conditions shows consistently increased time spent awake in epileptic animals (red) over age-matched WT (blue). E-J, Bout length distributions were also altered in epileptic mice (red lines) when compared to controls (blue lines). Two-sample Kolmogorov-Smirnov analysis shows cumulative distribution function (CDF) of bout lengths in Kcna1-null mice is altered for wake (E) and NREM (G) in diurnal condition and wake (F), NREM (H), and REM (J) in constant condition ( ‡P << .0001). Triangles above CDF plots indicate maximum bout lengths of Kcna1-null (red) or WT (blue) (n = 5-8/genotype/time point/lighting condition). We found significant oscillations over time in PER2 in both LD (Figure 5G , F 3, 40 = 3.79, P < .05, two-way ANOVA) and DD ( Figure 5H , F 3, 32 = 3.856, P < .05, two-way ANOVA). We found a main effect of genotype only in PER2 expression of mice held in DD ( Figure 5H , F 1, 32 = 4.761, P < .05, two-way ANOVA). Representative Western blots are shown in Figure 5K .
In summary, we found that the majority of genotype effects were at the transcript level, PER2 being the only tested protein altered in epileptic animals. Overall, epileptic Kcna1-null mice showed dampened amplitude of oscillation and decreased average expression for Clock, Per1, and Per2 in LD and Per1 and PER2 in DD, when compared with age-matched WT littermates.
| Sirt1 expression patterns in Kcna1-null mice
Considering the dampened transcription of several clock genes in Kcna1-null mice, and because Sirt1 has been implicated in regulation of clock components in aging, we sought to determine whether Sirt1 expression is altered in epileptic Kcna1-null mice using samples from above experiments. 18, 25 In LD-entrained animals, we found a main effect of genotype and time in transcript levels ( Figure 4I , F 1, 16 = 21.19 and F 3, 16 = 14.19, respectively, P < .001, two-way ANOVA). Again, expression level of Sirt1 mRNA in Kcna1-null animals was lower than WT, especially at ZT 6 (P < .05, Sidak) in LD. However, we did not find any significant differences in SIRT1 protein expression levels under LD or DD ( Figure 5I and 5J ).
| Clock gene and Sirt1 expression is not affected in young Kcna1-null mice
As an important control to ensure that the simple absence of Kv1.1 channels did not play a significant role in clock gene expression alterations, we assessed gene transcription patterns at P30, an age at which seizures are uncommon. We found no significant effects of genotype in the expression of any clock genes or Sirt1 at this younger age (Figure 6A and 6B, two-way ANOVA, P > .05, n = 3-4/time point/genotype), although single-time point analysis did indicate an increase in Per2 levels in epileptic animals over WT littermates (P < .05, Sidak). These findings suggest that genotype alone does not affect circadian rhythm maintenance, which is consistent with previous findings that rest-activity patterns in Kcna1-null mice did not differ from WT controls at this age. 
| DISCUSSION
There are several key observations in the present study. First, we found that epileptic Kcna1-null mice have altered locomotor rest-activity patterns and prolonged mean circadian period compared to WT controls, regardless of lighting condition. EEG sleep-wake analysis also showed that epileptic mice spent significantly less time in sleep, with altered sleep architecture as shown by differences in bout length distributions. We found that oscillations in transcript expression of several clock genes (Clock, Per1, and Per2) as well as a regulator, Sirt1, were attenuated in epileptic mice, especially under diurnal condition. Lack of any direct correlation between daily seizure burden and sleep parameters suggests that other mechanisms, such as the dampened oscillation of clock-controlled genes, may be such a mechanism of disrupted circadian rhythm and sleep in this model. Sleep patterns and circadian rhythms are known to be disturbed in many neurological conditions such as Parkinson and Alzheimer diseases. 26 Among patients with epilepsy, an association between circadian rhythms and seizures had been reported. For example, frontal lobe seizures tend to occur more out of sleep and in temporal lobe epilepsy spike probability in hippocampus is highest during slow-wave sleep. 27, 28 In animal models, susceptibility to kindled seizures peaks late in the day, whereas postkindling seizures occur more at subjective night and postkainate seizures during inactive periods. 29, 30 We previously showed that seizures in Kcna1-null have a periodicity peaking at around ZT 7, a pattern that exists in both light-entrained and free-running conditions. 6 Clinically, it has been F I G U R E 3 Linear regression analysis of daily seizure counts versus number of wake bouts did not reveal a significant correlation (R = 0.045, P = .14). Overlaid are the best-fit line and 95% confidence intervals for the correlation. Additional analysis of other sleep metrics showed no significant effect of seizure count on mean bout length or bout count for wake, non-rapid eye movement sleep, or rapid eye movement sleep WALLACE ET AL. reported that seizures commonly have patterns of occurrence related to circadian rhythms, which vary depending on type of seizure and epilepsy. 8 Additionally, patients with epilepsy show disrupted circadian rhythm and reduced sleep duration. [30] [31] [32] In animal models of epilepsy, several biological processes with circadian rhythmicity have been shown to be disrupted. 5, 33, 34 Our observations are consistent with these previous reports where circadian rest-activity rhythms are disrupted to near total arrhythmia in behavior, and the mean circadian period of epileptic mice is prolonged independent of lighting condition compared to WT controls. 5, 35 Furthermore, analysis of sleep architecture showed reduced time asleep and altered distributions of bout lengths in epileptic mice. One factor potentially responsible for the observed disruption in circadian rest-activity patterns and sleep was the seizures themselves. However, we found no significant correlation between seizure burden and degree of sleep disruption. Another potential mechanism we investigated was altered circadian rhythmicity of clock gene expression. Under normal circumstances, BMAL1, Per1/2 expression oscillates in the SCN, whereas CLOCK typically has consistent expression across light/dark cycles. 36 Abnormalities in circadian rest-activity rhythms and attenuation in the oscillation of clock genes in SCN including Clock, Per1, and Per2 had been reported in aging and neurogenerative disease literature. [37] [38] [39] Clock gene regulation also changes in response to acute sleep deprivation as evidenced by altered CLOCK:BMAL1 E-box occupancy, and changes in relative mRNA abundance of several clock genes, although the consequences of sustained sleep perturbations (such as occur in epilepsy) for clock gene expression remain unclear. 40, 41 Given that we found dampened oscillation of multiple clock genes in Kcna1-null animals, especially under LD, and prior evidence that amplitude of clock gene expression positively correlates with strength of circadian rhythms, we propose that the altered circadian behavior is the result of perturbed transcriptional regulation in our model. It is interesting that the effects of seizures on clock genes were primarily limited to mRNA. Although protein levels seemed to be largely unaffected in this model, it is possible that patterns of posttranslational modifications or cellular localization account for the changes in transcription levels. 42 As is the case with Sirt1, it is possible that the effects on transcription we see in the core clock genes extend to transcription of numerous other "clock-controlled genes," which would have implications for other cellular processes. Stabilization of circadian CLOCK:BMAL1-mediated transcription might be the key to normalize behavioral rhythms and sleep patterns. Modulators of the circadian clock vary from light exposure to dietary habits and cellular metabolism. Although the latter affects clock gene regulation through multiple pathways (ie, ROR/REVERB, AMPK, and mTORC1), SIRT1 has been shown to affect circadian clock gene machinery through interactions with the CLOCK:BMAL1 transcription factor and PER2. [43] [44] [45] Mitigating metabolic stress with diet-based therapies has existed for millennia. Both ketogenic diet (KD), a therapy for intractable epilepsy, and caloric restriction have been shown to upregulate Sirt1 expression in the brain. 46 Enhancing SIRT1 function has further demonstrated its utility in restoring circadian rhythms in conditions where SIRT1 expression is diminished, such as aging. 18 A prior study showed that KD can rescue entrainment of diurnal rest-activity patterns in Kcna1-null mice, although the role of SIRT1 has not been directly investigated. 5, 47 Enhancement of SIRT1 activity may constitute part of the therapeutic effectiveness of KD, complementing its antiseizure effects by assisting recovery of normal circadian rhythms. Additionally, because Kcna1-null mice exhibit a progressive disruption in rest-activity patterns preceding death, it is possible the disruptions in sleep and circadian rhythms we observe may constitute an early phenotype of compromised sleep that may worsen concomitantly with seizure burden, potentially contributing to disease progression and mortality. 7 Although the significant changes we observed in diurnal Sirt1 mRNA did not extend to protein levels, it is possible that the changes we see in mRNA levels are a broader result of a reduction in transcriptional activation by the circadian clock, as seen in aging. 18 Considering the therapeutic efficacy of enhancing SIRT1 activity to restore circadian rhythms in aging, where clock gene expression and circadian rhythms are weak, SIRT1 modulation may be an effective tool to mitigate progressive sleep perturbations in Kcna1-null mice. In patients with epilepsy, the potency of disrupted sleep in triggering seizures coupled with evidence that seizures disrupt circadian sleep patterns supports the idea that these reciprocal interactions contribute to disease progression. Restoring rest-activity rhythms and sleep through modulation of clock-controlled gene oscillation may prevent disease progression and epilepsy-related mortality (eg, SUDEP) in the Kcna1-null model. Future studies will be designed to address this question directly.
There are several limitations to our study. First is the global deletion of Kcna1; its influence on mechanisms outside of rectifying currents (ie, SCN electrophysiological function) remains unclear and as yet untested. This limitation does not negate the utility of this model, especially considering such syndromes where genetic mutation or autoimmunity ablate expression of such channels, often leading to convulsions. 48 Further studies in models not confounded by genetic mutations are needed to clarify this limitation, although our evaluation of mRNA expression levels, combined with evidence reported by our collaborators on rest-activity levels in young (<P30) Kv1.1 KO animals, suggests that the phenotype of sleep perturbation in Kcna1-null mice emerges only after the onset of spontaneous seizures. 7 Technical complications excluded simultaneous actigraphy-EEG data acquisition, prohibiting us from correlating activity counts with EEG-based seizure frequency or sleep metrics. We had multiple individuals scoring sleep stages, which added variance in bout analyses. However, we believe the impact of multiple scorers to be minimal, considering great effort was made to standardize the implementation of our scoring criteria, reaching >90% similarity between scorers on recordings from both genotypes and conditions. Finally, we have not demonstrated a causal relationship between aberrant oscillation of clock genes and disrupted behavioral patterns. It is possible that targeting sleep (eg, with sleep aids) may restore clock gene oscillation, which we have not investigated here. Future experiments will aim to evaluate further the reciprocal nature of the relationship between seizures and SCN functions, as well as to determine the therapeutic effects of modulating SIRT1 activity. Such experiments will closely evaluate changes of other known clock-controlled genes, parsing protein modification and trafficking, and investigate the effect of modulating efficiency of CLOCK:BMAL transcriptional drive through SIRT1.
